2018. Real-world experience and clinical utility of a non-invasive gene expression rule-out test for melanoma and additional validation against high risk driver mutations in BRAF, NRAS and the TERT promoter. SKIN The Journal of Cutaneous Medicine. 2, (Dec. 2018), S69. DOI:https://doi.org/10.25251/skin.2.supp.69.